Literature DB >> 26430912

The Role of the Y Box Binding Protein 1 C-Terminal Domain in Vascular Endothelial Cell Proliferation, Apoptosis, and Angiogenesis.

Wei Wang1,2, Hong-jie Wang1, Bing Wang1, Ying Li3, Yan Qin1, Li-shuang Zheng1, Jin-sa Zhou4, Peng-huan Qu4, Jian-hong Shi1, Hai-song Zhang5.   

Abstract

Different domains of the multifunctional transcription factor Y-box binding protein 1 (YB1) regulate proliferation, differentiation, and apoptosis by transactivating or repressing the promoters of various genes. Here we report that the C-terminal domain of YB1 (YB1 CTD) is involved in endothelial cell proliferation, apoptosis, and tube formation. The oligo pull-down assays demonstrated that YB1 directly binds double-stranded GC box sequences in endothelial cells through the 125-220 amino acids. Adenovirus expression vectors harboring green fluorescent protein (GFP) or GFP-tagged YB1 CTD were constructed and used to infect EA.hy926 endothelial cells. Overexpression of the YB1 CTD significantly increased p21 expression, decreased cyclin B1 expression, and inhibited the proliferation of EA.hy926 cells. YB1 CTD overexpression also increased Bax and active caspase 3 expression, decreased Bcl-2 expression, and induced apoptosis in EA.hy926 cells. Furthermore, overexpression of the YB1 CTD significantly suppressed migration and tube formation in EA.hy926 cells. Finally, YB1 CTD decreased ERK1/2 phosphorylation in EA.hy926 cells. These findings demonstrated vital roles for YB1 in endothelial cell proliferation, apoptosis, and tube formation through transcriptional regulation of GC box-related genes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26430912     DOI: 10.1089/dna.2015.2908

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  7 in total

1.  Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells.

Authors:  Jui-Wen Ma; Chao-Ming Hung; Ying-Chao Lin; Chi-Tang Ho; Jung-Yie Kao; Tzong-Der Way
Journal:  Oncotarget       Date:  2016-09-13

2.  Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma.

Authors:  Chen Liang; Yunlong Ma; Lei Yong; Chenlong Yang; Peng Wang; Xiao Liu; Bin Zhu; Hua Zhou; Xiaoguang Liu; Zhongjun Liu
Journal:  Cancer Sci       Date:  2018-12-19       Impact factor: 6.716

3.  Long noncoding RNA GAS5 induces abdominal aortic aneurysm formation by promoting smooth muscle apoptosis.

Authors:  Xiang He; Shifei Wang; Mengsha Li; Lintao Zhong; Hao Zheng; Yili Sun; Yanxian Lai; Xiaoqiang Chen; Guoquan Wei; Xiaoyun Si; Yuan Han; Senlin Huang; Xinzhong Li; Wangjun Liao; Yulin Liao; Jianping Bin
Journal:  Theranostics       Date:  2019-07-28       Impact factor: 11.556

4.  Upregulation of OTUD7B (Cezanne) Promotes Tumor Progression via AKT/VEGF Pathway in Lung Squamous Carcinoma and Adenocarcinoma.

Authors:  Dan-Dan Lin; Yang Shen; Shu Qiao; Wen-Wen Liu; Lishuang Zheng; Ya-Nan Wang; Naipeng Cui; Yun-Fan Wang; Shuli Zhao; Jian-Hong Shi
Journal:  Front Oncol       Date:  2019-09-11       Impact factor: 6.244

5.  Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1.

Authors:  Li Tang; Da Wei; Xinyu Xu; Xuelian Mao; Dongping Mo; Linping Yan; Weiguo Xu; Feng Yan
Journal:  NPJ Breast Cancer       Date:  2021-07-16

6.  Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes.

Authors:  Kiyoko Setoguchi; Lin Cui; Nobutaka Hachisuka; Sumalee Obchoei; Kentaro Shinkai; Fuminori Hyodo; Kiyoko Kato; Fumito Wada; Tsuyoshi Yamamoto; Mariko Harada-Shiba; Satoshi Obika; Kenji Nakano
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-14

7.  miRNA-200c-3p promotes endothelial to mesenchymal transition and neointimal hyperplasia in artery bypass grafts.

Authors:  Dan Chen; Cheng Zhang; Jiangyong Chen; Mei Yang; Tayyab A Afzal; Weiwei An; Eithne M Maguire; Shiping He; Jun Luo; Xiaowen Wang; Yu Zhao; Qingchen Wu; Qingzhong Xiao
Journal:  J Pathol       Date:  2020-11-28       Impact factor: 9.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.